Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
Clinical trial NCT02888080 · COMPLETED
Trial details
- NCT number
- NCT02888080
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2019-03-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.